Evidence map›Paper›PMID 26438105›Full record

ArticleGenetics research2015

A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.

Zehra Agha, Zafar Iqbal, Tjitske Kleefstra, Christiane Zweier, Rolph Pfundt, Raheel Qamar, Hans VAN Bokhoven, Marjolein H Willemsen

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Genetics research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Zehra AghaDepartment of Environmental Sciences and Biotechnology,COMSATS Institute of Information and Technology Abottabad,Pakistan.
Zafar IqbalDepartment of Human Genetics,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,the Netherlands.
Tjitske KleefstraDepartment of Human Genetics,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,the Netherlands.
Christiane ZweierInstitute of Human Genetics,Friedrich-Alexander-University Erlangen-Nuremberg,Erlangen,Germany.
Rolph PfundtDepartment of Human Genetics,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,the Netherlands.
Raheel QamarDepartment of Biosciences,Faculty of Science,COMSATS Institute of Information Technology,Islamabad,Pakistan.
Hans VAN BokhovenDepartment of Human Genetics,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,the Netherlands.
Marjolein H WillemsenDepartment of Human Genetics,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,the Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLCOMSATS University Islamabad · PKFriedrich-Alexander-Universität Erlangen-Nürnberg · DERadboud Institute for Molecular Life Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report is regarding a Dutch female with microcephaly, mild intellectual disability (ID), gonadal dysgenesis and dysmorphic facial features with synophrys. Upon genotyping, an ~455 kb de novo deletion encompassing the first exon of NRXN1 was found. Bidirectional sequencing of the coding exons of the NRXN1 alpha isoform was subsequently performed to investigate the possibility of a pathogenic mutation on the other allele, but we could not find any other mutation. Previously, many heterozygous mutations as well as microdeletions in NRXN1 were shown to be associated with ID, autism, schizophrenia, and other psychiatric and psychotic disorders. Our results are in agreement with other reports that show that NRXN1 deletions can lead to ID, microcephaly and mild dysmorphic features. However, this is the first report of gonadal dysgenesis being associated with such deletions. It is not clear whether there is a causal relationship between the NRXN1 deletion and gonadal dysgenesis, but it is of interest that the FSHR gene, which encodes the follicle-stimulating hormone receptor causative correlation that is mutated in ovarian dysgenesis, is located proximal to the NRXN1 gene. Given that most of the females carrying NRXN1 deletions have been diagnosed at a prepubertal age, gynecologic screening of female carriers of a NRXN1 deletion is warranted.

Indexed as

Gene DeletionGonadal DysgenesisIntellectual DisabilityMicrocephalyAbnormalities, MultipleAdultCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalChromosome DeletionChromosomes, Human, Pair 2FemaleHumansNerve Tissue ProteinsNetherlandsNeural Cell Adhesion MoleculesReceptors, FSHCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalNerve Tissue ProteinsNeural Cell Adhesion MoleculesNRXN1 protein, humanReceptors, FSH

Identifiers

PMID26438105
PMCPMC6863645
OpenAlexW2204590482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.